Further to WQ85157, will the Minister provide an estimated timescale for the completion of Evusheld's COVID-19 efficacy trials?
Answered by Minister for Health and Social Services | Answered on 22/08/2022
Following a robust review of the available data, the multi-agency Rapid C-19 group and a UK National Expert Policy Working Group has concluded there is currently insufficient data on the duration of protection offered by Evusheld in relation to the Omicron variant. The UK government has therefore decided not to procure any doses at this time.